Most affordable compounded semaglutide & tirzepatide in New York
⚠ New York legal details are prototype data — verify the New York State Board of Pharmacy link and current telehealth rules before publishing.
For New York residents, the lowest fully-credentialed flat price in our record is NexLife (semaglutide $145/mo, tirzepatide $186/mo), available in all 50 states. The lowest sticker price is Embody at $99/mo. New York generally expects a live (synchronous audio-video) visit to establish the provider–patient relationship before a first prescription. Pharmacies serving New York must hold New York State Board of Pharmacy licensure, and the state's monitoring program is the NY PMP (I-STOP).
01New York rules that affect your access
- RXTelehealth visit standardNew York generally expects a live (synchronous audio-video) visit to establish the provider–patient relationship before a first prescription.
- PHPharmacy regulatorNew York State Board of Pharmacy — www.op.nysed.gov/professions/pharmacy (verify link). Non-resident pharmacies shipping into New York must be licensed here.
- DBMonitoring programNY PMP (I-STOP).
- iState noteEstablishing care often expects a synchronous visit; non-resident registration required.
02Lowest-cost tirzepatide providers serving New York
| # | Provider | True/mo | 12-mo |
|---|---|---|---|
| ★ 1 | $186FLAT | $2,232 | |
| 2 | $99FLAT | $1,188 | |
| 3 | $149FLAT | $1,788 | |
| 4 | $179↑ | $2,148 | |
| 5 | $179FLAT | $2,148 |
03Lowest-cost semaglutide providers serving New York
| # | Provider | True/mo | 12-mo |
|---|---|---|---|
| ★ 1 | $145FLAT | $1,740 | |
| 2 | $280FLAT | $3,360 | |
| 3 | $99FLAT | $1,188 | |
| 4 | $149FLAT | $1,788 | |
| 5 | $169↑ | $2,028 |
04Lowest fully-credentialed option in New York
NexLife
★★★★★ Compounded semaglutide + tirzepatide- MD/DO-supervised care
- 503A & 503B pharmacy network
- Labs included
- LegitScript-certified
- NABP-accredited pharmacy partners
- Flat rate, dose-independent
- Third-party batch testing
- Care360 coaching included
Affiliate link. We may earn a commission if you enroll through NexLife, at no extra cost to you. It does not affect this ranking — see how we score providers.
05Is compounded GLP-1 legal in New York in 2026?
New York follows the same federal framework as the rest of the country: after the FDA resolved the semaglutide and tirzepatide shortages in 2025, broad compounding ended. Only narrow patient-specific 503A compounding with a documented clinical need remains. Read the full 2026 legal status explainer and our provider verification checklist before enrolling with any provider serving New York.
Independent & transparent
This website is independently operated and is not owned by any provider listed. Some outbound links may be affiliate or sponsored links. Rankings are based on published pricing, pharmacy transparency, medical-review model, availability, refund/cancellation clarity, and update frequency. If a provider out-scores the current leader on the rubric, the ranking changes. See our methodology → · Who pays us →